- Anatomy Of The National Drug Code
- DSCSA: Special Privileges For The "Big-3" Wholesale Distributors, Part 1
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- The Case Against RFID In Pharma
- The Aggregation Hoax and PIA
- DSCSA: Special Privileges For The “Big-3″ Wholesale Distributors, Part 2
- Pharma Supply Chain Companies Organize To Establish Global Traceability Data Exchange Architecture
Posts Tagged ‘Supply Network Blog’
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
I rely heavily on RxTrace to understand what is changing with the DSCSA, the latest with the FDA and the industry in general.
Easy to understand summary and discussion of complex current topics.
RxTrace offers unique context and focus on our industry.
RxTrace distills the complexities of pharmaceutical supply chain issues to simple concepts and also accurately projects issues on the horizon that industry leaders and legislators should heed.
The information provided is up-to-date and provides a pragmatic presentation and discussion of the pertinent issues as they unfold. It is an excellent and comprehensive summary.
RxTrace is my go-to source for information surrounding the implementation and implications of the Drug Quality and Security Act.
Look forward to RxTrace News-helps me to better manage key issues
Been following RxTrace ever since some of the very first postings, and it’s one of my absolutely best sources of serious and thorough analyses, on an otherwise very delicate and complicated topic. Dirk’s writings and articles comes highly recommended, and I’m always looking forward to the next posting. Many thanks from Denmark for sharing your thoughts with us all.
The first website I visit on Monday mornings is RxTrace
RxTrace is informative and well-written. It’s my ‘go to’ source for information on serialization and DSCSA.
GS1 Healthcare US Publishes Updated Guidance For DSCSA wp.me/pN6hS-1vZ
September 19, 2014 (5:42)
Is Your Drug Exempt From The Federal Drug Supply Chain Security Act?You mentioned that, "as long as it is recognized by the FDA as a product that...
Dirk A. Rodgers
September 4, 2014 (1:15)
Is Your Drug Exempt From The Federal Drug Supply Chain Security Act? RevisitedPam, Thanks for the supportive comment. I'm not aware of anyone who writes a...
September 4, 2014 (12:45)
Is Your Drug Exempt From The Federal Drug Supply Chain Security Act? RevisitedGood afternoon Dirk, I truly enjoy reading your essays. I like how it expl...
August 25, 2014 (9:40)
Pharma Supply Chain Companies Organize To Establish Global Traceability Data Exchange ArchitectureDear Dirk, The rumours you heard in the early spring are true and we are s...
August 18, 2014 (9:20)
2014 Fall Conference Season PreviewDirk, thanks for the list. I'll be at the GS1 and HDMA events. Thinking about...